Cyrus Taraporevala Elected to Pfizer’s Board of Directors
July 01 2024 - 6:45AM
Business Wire
Pfizer Inc. (NYSE: PFE) today announced the election of Cyrus
Taraporevala to its Board of Directors, effective immediately. Mr.
Taraporevala, age 57, was also appointed to and will join the Audit
Committee and Compensation Committee of Pfizer’s Board.
Mr. Taraporevala served as President and Chief Executive Officer
at State Street Global Advisors from 2017 until his retirement in
2022. Prior to joining State Street, he held numerous leadership
roles in asset management, including at Fidelity, BNY Mellon, Legg
Mason, and Citigroup. Earlier in his career, Mr. Taraporevala was a
partner at McKinsey & Company, based in New York and
Copenhagen.
He serves on the boards of directors of Shell plc and
Bridgepoint Group plc.
Mr. Taraporevala received a Bachelor of Commerce in Financial
Accounting from Sydenham College, University of Bombay, and a
Master of Business Administration from Cornell University.
“We are pleased to welcome Cyrus Taraporevala to Pfizer’s Board
of Directors,” stated Albert Bourla, Pfizer Chairman and Chief
Executive Officer. “He brings vast experience in investment
management, financial markets plus leadership and global operations
more broadly that will be an asset to Pfizer and enable our
shareholders to continue to benefit from a Board representing a
balance of experience, competencies and perspectives.”
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every day,
Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our
responsibility as one of the world's premier innovative
biopharmaceutical companies, we collaborate with health care
providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For
175 years, we have worked to make a difference for all who rely on
us. We routinely post information that may be important to
investors on our website at www.Pfizer.com. In addition, to learn
more, please visit us on www.Pfizer.com and follow us on X at
@Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook
at Facebook.com/Pfizer.
Category: Corporate
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240701406556/en/
Media Contact: PfizerMediaRelations@Pfizer.com +1 (212) 733-1226
Investor Contact: IR@Pfizer.com +1 (212) 733-4848
Pfizer (NYSE:PFE)
Historical Stock Chart
From Jul 2024 to Aug 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Aug 2023 to Aug 2024